from 12.01 headache, high blood pressure. 24.01 seizure. hospitalization brain hemorrhage, aneurysm.; from 12.01 headache, high blood pressure. 24.01 seizure. hospitalization brain hemorrhage, aneurysm.; this case was received via regulatory authority (reference number: it-minisal02-841384) on 25-feb-2022 and was forwarded to moderna on 25-feb-2022. this regulatory authority case was reported by a consumer and describes the occurrence of cerebral haemorrhage (from 12.01 headache, high blood pressure. 24.01 seizure. hospitalization brain hemorrhage, aneurysm.) and aneurysm (from 12.01 headache, high blood pressure. 24.01 seizure. hospitalization brain hemorrhage, aneurysm.) in a 63-year-old male patient who received mrna-1273 (spikevax) (batch no. 030g21a) for covid-19 vaccination. no medical history information was reported. on 10-jan-2022, the patient received dose of mrna-1273 (spikevax) (intramuscular) 1 dosage form. on 12-jan-2022, the patient experienced cerebral haemorrhage (from 12.01 headache, high blood pressure. 24.01 seizure. hospitalization brain hemorrhage, aneurysm.) (seriousness criterion death) and aneurysm (from 12.01 headache, high blood pressure. 24.01 seizure. hospitalization brain hemorrhage, aneurysm.) (seriousness criterion death). the patient died on 12-jan-2022. it is unknown if an autopsy was performed. no concomitant drug details were reported. no treatment details were reported. company comment: this regulatory authority case concerns a 63 year old male with no medical history reported, who experienced the seroius ( fatal ) , unexpected. event of cerebral hemorrhage and serious ( fatal ) , unexpected event of aneurysm which occurred two days post vaccination with an unknown dose number of mrna-1273 vaccine. the patient died two days post vaccination and it is unknown if an autopsy was done. the cause of death was not reported. other details surrounding the events were not reported. the benefit -risk relationship of mrna -1273 ( moderna covid 19 vaccine) is not affected by this report.; reporter's comments: information requests.; sender's comments: this regulatory authority case concerns a 63 year old male with no medical history reported, who experienced the seroius ( fatal ) , unexpected. event of cerebral hemorrhage and serious ( fatal ) , unexpected event of aneurysm which occurred two days post vaccination with an unknown dose number of mrna-1273 vaccine. the patient died two days post vaccination and it is unknown if an autopsy was done. the cause of death was not reported. other details surrounding the events were not reported. the benefit -risk relationship of mrna -1273 ( moderna covid 19 vaccine) is not affected by this report